BACKGROUND AND PURPOSE: It has been suggested that Chagas disease (CD) and particularly CD cardiomyopathy are independent risk factors for cerebrovascular events. Strong evidence is scarce, cardioembolic and inflammatory mechanisms have been proposed, and most studies lack representative and well-matched controls. We sought to investigate CD, defined by positive serology, as an independent risk factor for stroke, by comparing patients admitted with ischemic stroke with representative control patients with a very similar cardiovascular risk factor profile. METHODS: We performed a case-control study with 101 consecutive stroke patients and 100 consecutive acute coronary syndrome patients admitted to an emergency hospital. CD was investigated in all patients and was confirmed when both immunofluorescence and hemagglutination tests were positive. Clinical, laboratory, and ECG findings were analyzed. RESULTS: We found that age (P=0.006), female sex (P=0.01), systolic blood pressure (P=0.001), diastolic blood pressure (P=0.03), previous stroke/transient ischemic attack history (P<0.001), atrial fibrillation (P=0.005), other arrhythmias (P=0.05), and CD-positive serology (P=0.002) were more frequent among stroke patients than among patients with acute coronary syndromes. After a multivariable analysis with a backward elimination procedure, previous stroke/transient ischemic attack history (odds ratio=6.98; 95% CI, 2.99 to 16.29), atrial fibrillation (odds ratio=4.52; 95% CI, 1.45 to 14.04), and CD-positive serology (odds ratio=7.17; 95% CI, 1.50 to 34.19) remained independently associated with stroke. CONCLUSIONS: CD seems to be an independent risk factor for ischemic stroke. For patients in or coming from endemic regions, CD should be considered an etiologic or contributing factor for stroke.
BACKGROUND AND PURPOSE: It has been suggested that Chagas disease (CD) and particularly CD cardiomyopathy are independent risk factors for cerebrovascular events. Strong evidence is scarce, cardioembolic and inflammatory mechanisms have been proposed, and most studies lack representative and well-matched controls. We sought to investigate CD, defined by positive serology, as an independent risk factor for stroke, by comparing patients admitted with ischemic stroke with representative control patients with a very similar cardiovascular risk factor profile. METHODS: We performed a case-control study with 101 consecutive strokepatients and 100 consecutive acute coronary syndromepatients admitted to an emergency hospital. CD was investigated in all patients and was confirmed when both immunofluorescence and hemagglutination tests were positive. Clinical, laboratory, and ECG findings were analyzed. RESULTS: We found that age (P=0.006), female sex (P=0.01), systolic blood pressure (P=0.001), diastolic blood pressure (P=0.03), previous stroke/transient ischemic attack history (P<0.001), atrial fibrillation (P=0.005), other arrhythmias (P=0.05), and CD-positive serology (P=0.002) were more frequent among strokepatients than among patients with acute coronary syndromes. After a multivariable analysis with a backward elimination procedure, previous stroke/transient ischemic attack history (odds ratio=6.98; 95% CI, 2.99 to 16.29), atrial fibrillation (odds ratio=4.52; 95% CI, 1.45 to 14.04), and CD-positive serology (odds ratio=7.17; 95% CI, 1.50 to 34.19) remained independently associated with stroke. CONCLUSIONS: CD seems to be an independent risk factor for ischemic stroke. For patients in or coming from endemic regions, CD should be considered an etiologic or contributing factor for stroke.
Authors: Vinícius Viana Abreu Montanaro; Thiago Falcão Hora; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Eleonora Maria de Jesus Oliveira; Gabriel R de Freitas Journal: Neurol Sci Date: 2019-07-30 Impact factor: 3.307
Authors: Maria A P Martins; Daniel D Ribeiro; Vandack A Nobre; Fabiana R Pereira; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro Journal: Eur J Clin Pharmacol Date: 2012-09-28 Impact factor: 2.953
Authors: Jamary Oliveira-Filho; Ana C P Ornellas; Cathy R Zhang; Luciana M B Oliveira; Théo Araújo-Santos; Valeria M Borges; Laís M G B Ventura; Francisco J F B Reis; Roque Aras; André M Fernandes; Jonathan Rosand; Steven M Greenberg; Karen L Furie; Natalia S Rost Journal: J Stroke Cerebrovasc Dis Date: 2015-05-06 Impact factor: 2.136
Authors: Thaís Aparecida Reis Lage; Julia Teixeira Tupinambás; Lucas Bretas de Pádua; Matheus de Oliveira Ferreira; Amanda Cambraia Ferreira; Antonio Lucio Teixeira; Maria Carmo Pereira Nunes Journal: Rev Soc Bras Med Trop Date: 2022-06-06 Impact factor: 2.141
Authors: Vinícius Viana Abreu Montanaro; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Edson Marcio Negrão; Gabriel R de Freitas Journal: J Neurol Date: 2016-09-13 Impact factor: 4.849
Authors: Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro Journal: Expert Rev Cardiovasc Ther Date: 2015-10-23
Authors: José Alberto Martins da Matta; Roque Aras; Cristiano Ricardo Bastos de Macedo; Cristiano Gonçalves da Cruz; Eduardo Martins Netto Journal: PLoS One Date: 2012-04-16 Impact factor: 3.240